CFDE Data Portal | Search RPS6KA1

	Label	Description
	RPS6KA1 Gene (Entity type)	ENSG00000117676 - ribosomal protein S6 kinase A1
	SEC16A Gene (Entity type)	ENSG00000148396 - SEC16 homolog A, endoplasmic reticulum export factor
	NSA2 Gene (Entity type)	ENSG00000164346 - NSA2 ribosome biogenesis factor
	RPS6KA1 associations Collection (Entity type)	Associations for RPS6KA1_associations
	COX7A2L Gene (Entity type)	ENSG00000115944 - cytochrome c oxidase subunit 7A2 like
	GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	PHIP Gene (Entity type)	ENSG00000146247 - PHIP subunit of CUL4-Ring ligase complex
	GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	BSCL2 Gene (Entity type)	ENSG00000168000 - BSCL2 lipid droplet biogenesis associated, seipin
	GSE110178 2 V 3 TRANYLCYPROMINE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

RPS6KA1

ENSG00000117676 - ribosomal protein S6 kinase A1

SEC16A

ENSG00000148396 - SEC16 homolog A, endoplasmic reticulum export factor

NSA2

ENSG00000164346 - NSA2 ribosome biogenesis factor

RPS6KA1 associations

Associations for RPS6KA1_associations

COX7A2L

ENSG00000115944 - cytochrome c oxidase subunit 7A2 like

GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

PHIP

ENSG00000146247 - PHIP subunit of CUL4-Ring ligase complex

GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP

A Gene Set from LINCS

BSCL2

ENSG00000168000 - BSCL2 lipid droplet biogenesis associated, seipin

GSE110178 2 V 3 TRANYLCYPROMINE MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.